Denmark· DK-28106139118
Giapreza
A angiotensin ii product containing angiotensin ii acetat, registered in Denmark by PAION Deutschland GmbH. The same ATC class is registered in 11 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Angiotensin ii is registered in 11 of 19 countries.
Countries holding a registration under ATC C01CX09 (angiotensin ii), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 7 of them publish a price we can compare per daily dose
Angiotensin ii · ATC C01CX09
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Angiotensin II acetat
- Manufacturer
- PAION Deutschland GmbH
- Country
- Denmark (DK)
- ATC code
- C01CX09
- ATC class
- Angiotensin II
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106139118
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under C01CX09
Angiotensin ii, as other registers publish it.
- United StatesANGIOTENSIN IIGland Pharma Limited
- United StatesGiaprezaLa Jolla Pharmaceutical Company
- United StatesGiaprezaLa Jolla Pharmaceutical Company
- PolandGiaprezaPAION Pharma GmbH
- IcelandGiaprezaPAION Pharma GmbH
- United StatesGiaprezaLa Jolla Pharmaceutical Company
- United StatesGiaprezaLa Jolla Pharmaceutical Company
- FinlandGiaprezaPAION Pharma GmbH
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/42327b58-0d91-41b0-b16b-da72dc24b2bc GET /v1/drugs/42327b58-0d91-41b0-b16b-da72dc24b2bc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "koncentrat til infusionsvæske, opløsning",
"source": "dkma",
"strength": "2,5 mg/ml",
"auth_role": "MOD",
"dk_drugid": "28106139118",
"substance": "Angiotensin II acetat",
"auth_procedure": "Central",
"in_medicinpriser": true,
"registration_date_serial": "43700"
}See everything about angiotensin ii.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.